IPAR vs LRLCY: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

LRLCY is the larger of the two ($264.66B market cap): the incumbent the market prices for continued execution (28.20x forward earnings, beta 0.85). IPAR is the smaller challenger ($4.36B), priced similarly on forward earnings (26.75x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.

IPAR vs LRLCY: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricIPARLRLCYWhat it tells you
Market cap$4.36B$264.66BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E26.7528.20Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Trailing P/E25.6336.09Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price.
Beta1.090.85Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range97% of range86% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book4.966.95How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Before you buy: how IPAR and LRLCY affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. IPAR and LRLCY share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined IPAR and LRLCY exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Inter Parfums, Inc. (IPAR) do?

Interparfums creates, manufactures and distributes prestige fragrances under licence from brand owners. It signs a multi-year agreement with a fashion or jewellery house, pays that house a royalty of roughly 6% to 11% of net sales, and takes on everything else: the juice, the bottle, the positioning, the advertising and the distribution into more than 120 countries. The business runs in two segments. European based operations sit inside Interparfums SA, a separately listed Paris subsidiary that Interparfums owns 72% of, and carry Jimmy Choo, Coach, Montblanc, Lacoste, Boucheron, Kate Spade, Karl Lagerfeld, Moncler and Van Cleef & Arpels; that side was about 68% of 2025 net sales. United States based operations carry GUESS, Donna Karan/DKNY, Ferragamo, Abercrombie & Fitch, Hollister, MCM, Roberto Cavalli, Graff, Oscar de la Renta and Anna Sui. A handful of brands are owned outright rather than licensed, including Rochas, Lanvin, Off-White, Goutal and the in-house Solférino line.

Full IPAR guide

What does L'Oréal S.A. (LRLCY) do?

L'Oréal S.A. is a Paris-based beauty group with more than 35 international brands sold in about 150 countries. It makes money by selling skincare, makeup, hair care and fragrance through four divisions: Consumer Products (L'Oréal Paris, Maybelline, Garnier), the largest by sales; L'Oréal Luxe (Lancôme, Yves Saint Laurent Beauté, Armani, Prada, Valentino, Aesop and, since April 2026, Creed); Dermatological Beauty (La Roche-Posay, CeraVe, Vichy, SkinCeuticals); and Professional Products (Kérastase, Redken), sold through salons. The Bettencourt Meyers family owns roughly a third of the company and Nestlé about a fifth. LRLCY is an unsponsored ADR that trades in dollars and tracks the Euronext Paris share (ticker OR) adjusted for the euro-dollar rate.

Full LRLCY guide

IPAR vs LRLCY: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

  • IPAR drivers: The licence book runs long where the revenue is; A staggered pipeline of new names.
  • LRLCY drivers: Dermatological Beauty; Luxury fragrance and Kering Beauté.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: The structural risk is that Interparfums does not own most of what it sells, and a licensor can decline to renew or take fragrance in-house, as Alfred Dunhill did when that agreement lapsed on September 30, 2023 without renewal. For LRLCY, valuation is the main risk.

IPAR or LRLCY: which should you pick?

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick IPAR if you believe its drivers more; LRLCY if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the IPAR and LRLCY guides.

IPAR vs LRLCY: the full fundamentals

IPAR. The multiple sits close to the broad market even though the earnings line is guided down this year, and the stock is up about 35% in 2026, which suggests the market is pricing the 2027 and 2028 launch slate (now including PUMA) rather than the current run rate. Analysts' average target of about $126.50 sits roughly 9% above the October 16, 2026 close. Three brokers cut the stock to a hold rating in August 2026 on exactly that reasoning, arguing the pipeline was already in the price. Royalty expense of ~$121.7 million in 2025, about 8.2% of sales, is the recurring cost of the licensing model and rises with brand mix rather than with volume alone.

LRLCY. L'Oréal has long traded at a premium to consumer-staples peers because of its steady growth and expanding margins. First-half 2026 net profit excluding one-off items was ~€3.96 billion, up 4.7%, and reported attributable net profit was ~€3.55 billion. LRLCY traded between about $78.82 and $95.48 over the past year. Analysts expect 2026 revenue of roughly €47.0 billion, up about 6.8%, and around €50.0 billion in 2027. The third-quarter sales release on October 22, 2026 (after the Paris close) is the next test of whether the faster first-half pace carried into the second half.

Headline figures (approximate, October 2026): IPAR shows revenue (ttm) ~$1.50B, up ~2% year over year in the latest quarter, diluted eps (ttm) ~$5.24, against 2026 guidance of ~$4.85; Q2 2026 EPS $0.95 vs $0.97 expected, net income (ttm) ~$168M, operating margin (h1 2026) ~17.9%, down from ~20.0% a year earlier; gross margin ~58% TTM; LRLCY shows revenue (ttm) ~€45.4 billion (~$53 billion), h1 2026 sales growth (like-for-like) ~6.8% (Q2 alone ~6.0%), operating margin (h1 2026) ~21.3%, a first-half record, market cap ~$242 billion.

The bottom line: IPAR vs LRLCY

IPAR and LRLCY are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined IPAR and LRLCY exposure against your real portfolio. It is not an investment adviser.

Wondering how IPAR or LRLCY fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Inter Parfums, Inc.

Ask Walnut's AI anything about IPAR and see how it fits what you own.

FAQ

What is the difference between IPAR and LRLCY?

+

Interparfums creates, manufactures and distributes prestige fragrances under licence from brand owners. L'Oréal S.A. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is IPAR or LRLCY the better stock?

+

Neither is universally better. LRLCY is the larger incumbent; IPAR is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, IPAR or LRLCY?

+

On forward P/E (as of November 2026), IPAR trades at 26.75x and LRLCY at 28.20x, so IPAR is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both IPAR and LRLCY?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of IPAR vs LRLCY?

+

IPAR: The structural risk is that Interparfums does not own most of what it sells, and a licensor can decline to renew or take fragrance in-house, as Alfred Dunhill did when that agreement lapsed on September 30, 2023 without renewal. Three smaller licences reach their stated end on December 31, 2026 (Anna Sui, Graff and Moncler), each with an optional extension that depends on conditions or sales targets being met, while Boucheron's main lines run to the end of 2027 and Abercrombie & Fitch and Hollister expire on March 14, 2028. Concentration compounds the point, because roughly 77% of sales sit in seven brands and Macy's alone was about 10% of 2025 net sales. Currency is a live swing factor given that about half of European segment sales are billed in dollars while nearly all of that segment's costs are in euro. There is also an option on the Lanvin trademarks that lets the seller repurchase them on July 1, 2027 for 70 million euro, roughly $82 million, which would remove an owned brand from the portfolio, and the 2026 guidance itself implies lower earnings than 2025 as advertising spend climbs back toward the company's 21% of sales target. Valuation is another consideration after the 2026 rally: at roughly 22 times trailing earnings and a similar multiple on 2027 estimates of about $5.20, the shares already price in much of the launch slate, and six analysts tracked carry a consensus hold rating. LRLCY: Valuation is the main risk. At roughly 33 times trailing earnings, a modest growth miss can move the shares sharply, as happened in October 2025 when third-quarter like-for-like growth of 4.2% came in below expectations. Consensus now looks for third-quarter 2026 revenue of about €11.2 billion, up roughly 8.6% on a reported basis, so the bar for the October 22 release is high. Consumer Products, the largest division, grew only 4.1% in the first half, and mass beauty in the US and Europe faces competition from cheaper indie and private-label brands. China's recovery has been uneven, and travel retail remains volatile. Kering Beauté adds integration risk and ties part of Luxe to the health of fashion houses whose brands L'Oréal licenses rather than owns. Professional Products' double-digit growth partly reflects pricing, which may not repeat. For US holders, a stronger dollar reduces returns, the OTC ADR can trade thinly with wider spreads, and French withholding tax applies to dividends.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell IPAR or LRLCY; figures are approximate and dated (as of November 2026). Verify current data before investing.